PHS
APTX

PFM Health Sciences’s Aptinyx Inc. Common Stock APTX Stock Holding History

PFM Health Sciences’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,795,149
Closed -$7.27M – 106
2019
Q1 		$7.27M Sell
1,795,149
-56,983
-3% -$413K 0.16% 83
2018
Q4 		$30.6M Buy
1,852,132
+97,453
+6% +$2.31M 0.81% 49
2018
Q3 		$49.5M Buy
1,754,679
+374,763
+27% +$9.11M 0.73% 52
2018
Q2 		$32.1M Buy
+1,379,916
New +$29.5M 0.5% 73

Other funds holding APTX

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PFM Health Sciences's APTX Position: Q2 2019 in Review

PFM Health Sciences sold out of Aptinyx Inc. Common Stock (APTX) in Q2 2019, closing a stake of 1,795,149 shares — an estimated $7.27M sold.

PFM Health Sciences first reported a position in APTX in Q2 2018 and held it in 4 quarters. The position peaked at $49.5M in Q3 2018. 57 funds tracked by Wall St. Rank hold APTX as of Q2 2019.

  • PFM Health Sciences reported no remaining Aptinyx Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • PFM Health Sciences sold 1,795,149 Aptinyx Inc. Common Stock shares in Q2 2019, an estimated $7.27M.
  • PFM Health Sciences first reported a position in Aptinyx Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • PFM Health Sciences's Aptinyx Inc. Common Stock position peaked at $49.5M in Q3 2018.
  • 57 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q2 2019.

Based on PFM Health Sciences's 13F filing for Q2 2019, filed 14 Aug 2019.